✦ LIBER ✦

Cavernous hemangiomas in patients with chronic liver disease: MR imaging findings

✍ Scribed by Maria Mastropasqua; Masayuki Kanematsu; Polytimi Leonardou; Larissa Braga; John T Woosley; Richard C Semelka

Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 134 KB
Volume: 22
Category: Article
ISSN: 0730-725X
DOI: 10.1016/j.mri.2003.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preventing acute liver disease in patien

Preventing acute liver disease in patients with chronic liver disease

✍ Maria H. Sjogren 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 23 KB 👁 1 views

Carnitine metabolism in patients with ch

Carnitine metabolism in patients with chronic liver disease

✍ S. Krähenbühl; J. Reichen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

with consequent organ dysfunction. Carnitine metabolism Carnitine metabolism was studied in 79 patients with could be disturbed by a variety of mechanisms in patients chronic liver disease, including 22 patients with noncirwith chronic liver disease. Dietary intake of carnitine could rhotic liver di

Platelet autoantibodies in patients with

Platelet autoantibodies in patients with chronic liver disease

✍ Dr. Jaime Pereira; Luigi Accatino; Jorge Alfaro; Javier Brahm; Patricia Hidalgo; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

MR findings in a patient with Caffey's d

MR findings in a patient with Caffey's disease

✍ I. Saatci; J. J. Brown; W. H. McAlister 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Elevated rubella antibodies in patients

Elevated rubella antibodies in patients with chronic liver disease

✍ May Britt Kalvenes; Reinhardt Flø; Karl-Henning Kalland; Gunnar Haukenes 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 700 KB

## Abstract Patients with autoimmune chronic active hepatitis (AICAH) and certain other chronic liver disorders often have very high titres of haemagglutination ‐inhibition (HI) antibodies to rubella virus. In this study it is shown, using floatation centrifugation, that the high rubella HI reactiv

Pharmacokinetics of isradipine in patien

Pharmacokinetics of isradipine in patients with chronic liver disease

✍ J. Cotting; J. Reichen; K. Kutz; R. Laplanche; E. Nüesch 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 523 KB

The pharmacokinetics of the dihydropyridine calcium antagonist isradipine has been examined in 8 healthy volunteers, 7 patients with non-cirrhotic chronic liver disease (CLD), and 8 patients with biopsy-proven cirrhosis (CIR). Isradipine was simultaneously given orally (12C 5 mg) and i.v. (13C 1 mg)